BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38232629)

  • 1. Comparative transcriptomic analyses reveal activation of the epithelial-mesenchymal transition program in non-metastasizing low grade pseudomyxoma peritonei.
    Pretzsch E; Neumann J; Nieß H; Pretzsch CM; Hofmann FO; Kirchner T; Klauschen F; Werner J; Angele M; Kumbrink J
    Pathol Res Pract; 2024 Feb; 254():155129. PubMed ID: 38232629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E; Kirchner T; Mayr D
    Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the molecular mechanisms and signalling pathways of epithelial to mesenchymal transition (EMT) in colorectal cancer: A systematic review and bioinformatic analysis of gene expression.
    Azizan S; Cheng KJ; Mejia Mohamed EH; Ibrahim K; Faruqu FN; Vellasamy KM; Khong TL; Syafruddin SE; Ibrahim ZA
    Gene; 2024 Feb; 896():148057. PubMed ID: 38043836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare, low-grade appendiceal mucinous neoplasm (Pseudomyxoma peritonei) with ossification: A case report with morphoproteomic analysis of bone formation.
    Noh BJ; Kim YW; Park YK
    Pathol Res Pract; 2016 Nov; 212(11):1085-1088. PubMed ID: 27712976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Pseudomyxoma Peritonei of an unexpected origin.
    Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
    Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidental finding of mucinous neoplasia of the appendix : Treatment strategies].
    Köhler F; Rosenfeldt M; Matthes N; Kastner C; Germer CT; Wiegering A
    Chirurg; 2019 Mar; 90(3):194-201. PubMed ID: 30456645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
    Sabouni E; Nejad MM; Mojtabavi S; Khoshduz S; Mojtabavi M; Nadafzadeh N; Nikpanjeh N; Mirzaei S; Hashemi M; Aref AR; Khorrami R; Nabavi N; Ertas YN; Salimimoghadam S; Zandieh MA; Rahmanian P; Taheriazam A; Hushmandi K
    Biomed Pharmacother; 2023 Apr; 160():114395. PubMed ID: 36804124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
    Guaglio M; Sinukumar S; Kusamura S; Milione M; Pietrantonio F; Battaglia L; Guadagni S; Baratti D; Deraco M
    Ann Surg Oncol; 2018 Apr; 25(4):878-884. PubMed ID: 29270877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
    Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
    Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
    Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
    Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
    Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
    Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
    Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.